London, United Kingdom

Fares Haddad

This inventor holds 1 USPTO granted patent. Top assignee: Howmedica Osteonics Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fares Haddad. Retrieved from https://idiyas.com/inventor/fares-haddad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fares Haddad and the Hip Stem Alignment Guide.

Introduction

Fares Haddad is an inventor associated with London, United Kingdom, and Howmedica Osteonics Corporation. His listed patent concerns a guide designed to assist with alignment during joint prosthesis procedures.

Latest Patents

Haddad is credited with 1 patent, titled “Hip Stem Alignment Guide.” The invention describes a guide body with an opening that receives a prosthesis trunnion and a through-hole containing an axially movable alignment member. A locking member can engage the alignment member to secure it in position, helping maintain alignment during use.

Career Highlights

The available information identifies Haddad’s work on the hip stem alignment guide and his association with Howmedica Osteonics Corporation. The patent focuses on a mechanical feature for positioning and stabilizing an alignment member on a joint prosthesis.

Collaborations

Polina Canepa and Katrina David are listed as Haddad’s coworkers. The provided information does not specify their roles in the patent or the invention.

Conclusion

Fares Haddad’s listed patent presents a prosthesis-mounted alignment guide with a lockable, adjustable member, reflecting his documented contribution to medical-device innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…